Fermenta Biotech Intrinsic Value
FERMENTA • Healthcare
Current Stock Price
₹319.05
Primary Intrinsic Value
₹545.60
Market Cap
₹478.6 Cr
+50.0%
Upside
Median Value
₹478.67
Value Range
₹159 - ₹638
Assessment
Trading Below Calculated Value
Safety Margin
33.3%
FERMENTA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹545.60 | ₹436.48 - ₹654.72 | +71.0% | EPS: ₹24.80, Sector P/E: 22x |
| Book Value Method | asset | ₹478.67 | ₹430.80 - ₹526.54 | +50.0% | Book Value/Share: ₹239.33, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹638.10 | ₹574.29 - ₹701.91 | +100.0% | Revenue/Share: ₹362.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹638.10 | ₹574.29 - ₹701.91 | +100.0% | EBITDA: ₹128.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹253.76 | ₹203.01 - ₹304.51 | -20.5% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹158.72 | ₹142.85 - ₹174.59 | -50.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹383.16 | ₹344.84 - ₹421.48 | +20.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹638.10 | ₹574.29 - ₹701.91 | +100.0% | ROE: 20.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹365.44 | ₹328.90 - ₹401.98 | +14.5% | EPS: ₹24.80, BVPS: ₹239.33 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
FERMENTA Intrinsic Value Analysis
What is the intrinsic value of FERMENTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Fermenta Biotech (FERMENTA) is ₹478.67 (median value). With the current market price of ₹319.05, this represents a +50.0% variance from our estimated fair value.
The valuation range spans from ₹158.72 to ₹638.10, indicating ₹158.72 - ₹638.10.
Is FERMENTA undervalued or overvalued?
Based on our multi-method analysis, Fermenta Biotech (FERMENTA) appears to be trading below calculated value by approximately 50.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.61 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 20.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.88x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Fermenta Biotech
Additional stock information and data for FERMENTA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹41 Cr | ₹41 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹105 Cr | ₹97 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹116 Cr | ₹89 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹43 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹63 Cr | ₹43 Cr | Positive Free Cash Flow | 8/10 |